OSCAR HEALTH INC - CLASS A (OSCR)

US6877931096 - Common Stock

13.4952  -0.59 (-4.22%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
1.839B
297.30%
3.964B
115.57%
5.863B
47.92%
9.445B
61.10%
11.782B
24.74%
11.937B
1.32%
14.863B
24.51%
EBITDA
YoY % growth
-529.9M
-35.52%
-574.6M
-8.44%
-204.921M
64.34%
203.44M
199.28%
437.1M
114.85%
613.64M
40.39%
833.49M
35.83%
EBIT
YoY % growth
-544.5M
-35.35%
-589.9M
-8.34%
-235.615M
60.06%
55.148M
123.41%
286.02M
418.64%
460.05M
60.85%
629.89M
36.92%
Operating Margin
-29.61%-14.88%-4.02%0.58%2.43%3.85%4.24%
EPS
YoY % growth
-3.30-2.85
13.64%
-1.20
57.89%
0.02
101.28%
0.77
4,913.33%
1.16
50.95%
1.80
55.49%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.61
7.49%
0.70
12.42%
0.39
95.50%
0.07
134.00%
-0.34
44.87%
0.72
3.90%
0.37
-6.09%
0.13
68.18%
-0.26
23.23%
Revenue
Q2Q % growth
2.529B
76.65%
2.882B
34.53%
3.034B
36.71%
3.057B
26.14%
3.094B
22.34%
2.939B
1.98%
2.998B
-1.19%
2.986B
-2.32%
2.979B
-3.72%
EBITDA
Q2Q % growth
-114.559M
0.20%
282.19M
45.93%
171.09M
105.58%
79.567M
412.49%
-59.692M
47.89%
296.7M
5.14%
181.01M
5.80%
97.315M
22.31%
-25.366M
57.51%
EBIT
Q2Q % growth
-153.951M
-5.83%
241.42M
30.10%
144.59M
113.22%
42.418M
187.69%
-79.658M
48.26%
262.01M
8.53%
146.04M
1.00%
62.034M
46.24%
-62.911M
21.02%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.22
24.14%
-0.17-0.05-25.82%
Q2 2024
Q2Q % growth
0.20
385.71%
0.160.0421.28%
Q1 2024
Q2Q % growth
0.62
444.44%
0.280.34123.47%
Q4 2023
Q2Q % growth
-0.66
37.14%
-0.740.0810.44%
Q3 2023
Q2Q % growth
-0.29
68.13%
-0.480.1939.83%
Q2 2023
Q2Q % growth
-0.07
86.79%
-0.230.1670.16%
Q1 2023
Q2Q % growth
-0.18
50.00%
-0.05-0.13-247.73%
Q4 2022
Q2Q % growth
-1.05
-10.53%
-1.180.1311.26%
Q3 2022
Q2Q % growth
-0.91
10.78%
-0.75-0.16-22.13%
Q2 2022
Q2Q % growth
-0.53
-51.43%
-0.49-0.04-8.63%
Q1 2022
Q2Q % growth
-0.36
63.27%
-0.22-0.14-65.31%
Q4 2021
Q2Q % growth
-0.95 -0.980.033.38%
Q3 2021
Q2Q % growth
-1.02 -0.67-0.35-51.69%
Q2 2021
Q2Q % growth
-0.35 -0.470.1226.21%
Q1 2021
Q2Q % growth
-0.98 -0.54-0.44-80.07%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.423B
68.30%
2.386B37.482M1.57%
Q2 2024
Q2Q % growth
2.219B
45.86%
2.198B21.341M0.97%
Q1 2024
Q2Q % growth
2.142B
45.77%
2.051B91.305M4.45%
Q4 2023
Q2Q % growth
1.432B
43.87%
1.449B-17.342M-1.20%
Q3 2023
Q2Q % growth
1.44B
47.18%
1.448B-8.009M-0.55%
Q2 2023
Q2Q % growth
1.522B
49.57%
1.468B53.535M3.65%
Q1 2023
Q2Q % growth
1.47B
51.08%
1.169B300.685M25.72%
Q4 2022
Q2Q % growth
995.1M
100.58%
1.106B-110.9M-10.03%
Q3 2022
Q2Q % growth
978.4M
120.36%
981.41M-3.01M-0.31%
Q2 2022
Q2Q % growth
1.017B
92.20%
973.99M43.31M4.45%
Q1 2022
Q2Q % growth
972.8M
163.35%
781.59M191.21M24.46%
Q4 2021
Q2Q % growth
496.1M
214.58%
445.23M50.87M11.43%
Q3 2021
Q2Q % growth
444M
336.58%
422.49M21.51M5.09%
Q2 2021
Q2Q % growth
529.3M
359.06%
215.14M314.16M146.03%
Q1 2021
Q2Q % growth
369.4M
319.30%
216.98M152.42M70.25%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -2.61% -64% 50%
Revenue0% 14.75% 1.94% 2.44%